Citi analyst Joanne Wuensch raised the firm’s price target on Becton Dickinson (BDX) to $198 from $185.70 and keeps a Buy rating on the shares. The firm updated the company’s model to reflect the LifeSciences sale.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Becton Dickinson Launches $1.6 Billion Debt Tender Offers
- Under Armour cut to Sell, Snap upgraded: Wall Street’s top analyst calls
- Becton Dickinson price target lowered to $172 from $210 at RBC Capital
- Two new option listings and one option delisting on February 10th
- Waters resumed with an In Line at Evercore ISI